📰 Lupus Sci News
Lupus Sci News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lupus Sci. Real-time updates on events, politics, business and more.
June 23, 2023
Fatigue: a very common physical complaint that often accompanies depressive disorders.
January 4, 2023
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2, randomized, placebo-controlled trial to evaluate its development-stage medicine daxdilimab, a potentially
January 4, 2023
Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus
February 16, 2022
Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE
February 16, 2022
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE approved in ...
February 16, 2022
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosusSaphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosusAstraZeneca’s Saphnelo (anifrolumab) has been approved in the...
August 11, 2021
/PRNewswire/ -- Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in...
August 11, 2021
/PRNewswire/ -- Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in...
August 11, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.